SOLID MALIGNANCIES
Clinical trials for SOLID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancer: first human trial of SKB571 begins
Disease control Recruiting nowThis study tests a new drug called SKB571 in people with advanced solid tumors that have spread. The main goal is to check the drug's safety and find the right dose. About 138 adults aged 18-75 will take part. This is the first time SKB571 is being tested in humans.
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
New cancer drug combo trial launches for solid tumors
Disease control Recruiting nowThis early-phase study tests a new drug called CT7439, given alone or with other cancer treatments, in about 50 adults with solid tumors that have not responded to standard therapy. The main goal is to check the drug's safety and find the best dose. Researchers will monitor side …
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Carrick Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
New radioactive drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called 177Lu-IM-3050 in about 105 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. The drug delivers radiation directly to cancer cells to …
Matched conditions: SOLID MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New hope for advanced cancer? early trial of CMAB017 begins
Disease control Recruiting nowThis early-phase study tests a new drug called CMAB017 in about 55 people with advanced solid tumors (like head and neck, colorectal, or esophageal cancer) that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see …
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
New hope for advanced cancers: experimental drug IM-1021 enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called IM-1021 in people with advanced solid tumors or certain blood cancers (lymphomas) that have not responded to other treatments. The main goals are to check the drug's safety and find the best dose. About 117 adults will take part in t…
Matched conditions: SOLID MALIGNANCIES
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC